Trial Profile
Effect of Capecitabine on the Pharmacokinetics of BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Feb 2017
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary) ; Capecitabine
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 13 Nov 2005 New trial record.